Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neovascular Age-related Macular Degeneration (AMD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT01500915
What this trial is testing

FUSION Regimen: Combined Pro re Nata and Fixed Regimen Ranibizumab in Exudative Age-related Macular Degeneration

Who this might be right for
Exudative Age-related Macular Degeneration
Institut de la Macula y la Retina 17
Post-approval studies (Phase 4)Study completedNCT03355638
What this trial is testing

Treatment of CNV With Aflibercept Combined With Pranoprofen Eye Drops or Nutraceutical Support With Omega-3

Who this might be right for
Macular Edema
Università degli Studi di Brescia 60
Testing effectiveness (Phase 2)Study completedNCT01674569
What this trial is testing

Pilot Study of X-82 in Patients With Wet AMD

Who this might be right for
Exudative Macular Degeneration
Tyrogenex 35
Not applicableStudy completedNCT02173496
What this trial is testing

Colour Contrast Sensitivity for the Early Detection of Wet Age-related Macular Degereration (CEDAR)

Who this might be right for
Age Related Macular Degeneration
Aston University 233
Not applicableStudy completedNCT01773954
What this trial is testing

Repeated Eye Injections of Aflibercept for Treatment of Wet Age Related Macular Degeneration

Who this might be right for
Age-Related Macular DegenerationMacular Degeneration
MidAtlantic Retina 40
Not applicableStudy completedNCT03909425
What this trial is testing

Defining Disease Activity in Neovascular AMD With Optical Coherence Tomography Angiography

Who this might be right for
Neovascular Age-related Macular Degeneration
Moorfields Eye Hospital NHS Foundation Trust 35
Not applicableStudy completedNCT01819415
What this trial is testing

Omega-3 Supplementation and Vitreal VEGF Levels in Wet-AMD

Who this might be right for
Exudative Age Related Macular Degeneration
Maisonneuve-Rosemont Hospital 40
Early research (Phase 1)Study completedNCT03249740
What this trial is testing

A Depot Formulation of Sunitinib Malate (GB-102) in Subjects With Neovascular (Wet) Age-related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration
Graybug Vision 32
Early research (Phase 1)Study completedNCT01255462
What this trial is testing

Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration

Who this might be right for
Advanced Age-related Macular Degeneration
Novartis Pharmaceuticals 24
Not applicableStudy completedNCT06231121
What this trial is testing

Switching to Faricimab in Neovascular Age-related Macular Degeneration Resistant to Both Aflibercept and Ranibizumab

Who this might be right for
Neovascular Age-related Macular Degeneration
Rigshospitalet, Denmark 13
Not applicableStudy completedNCT05146687
What this trial is testing

Real-world Evaluation of Prevalence of Ocular Adverse Events in Patients With Neovascular (Wet) Age-related Macular Degeneration (AMD) Who Received Anti-vascular Endothelial Growth Factor (VEGF) Agents (Komodo Health)

Who this might be right for
Age-related Macular Degeneration (AMD)
Novartis Pharmaceuticals 369,600
Testing effectiveness (Phase 2)Study completedNCT00376701
What this trial is testing

Combination Therapy for Age-Related Macular Degeneration.

Who this might be right for
Age Related Macular Degeneration
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 103
Large-scale testing (Phase 3)Not Yet RecruitingNCT07816289
What this trial is testing

Phase 3 Study of Intravitreal OLN324 in Adults With Neovascular (Wet) Age-related Macular Degeneration (nAMD) (OLN324-CP-05)

Who this might be right for
Wet Age-related Macular Degeneration
Ollin Biosciences, Inc. 400
Not applicableStudy completedNCT00727753
What this trial is testing

VEGF-antagonism and Endothelial Function in Age-related Macular Degeneration (AMD)

Who this might be right for
Macular Degeneration
University of Zurich 54
Testing effectiveness (Phase 2)Looking for participantsNCT05672121
What this trial is testing

Safety and Tolerability of KH631 Gene Therapy in Subjects With Neovascular Age-related Macular Degeneration (nAMD)

Who this might be right for
Age-Related Macular Degeneration
Chengdu Origen Biotechnology Co., Ltd. 42
Testing effectiveness (Phase 2)Ended earlyNCT01189019
What this trial is testing

HiPED - High Dose Lucentis for Persistent Pigment Epithelial Detachments in Age-related Macular Degeneration

Who this might be right for
Wet Macular DegenerationMacular DegenerationRetinal Pigment Epithelial Detachment
Anne Fung MD 40
Large-scale testing (Phase 3)Study completedNCT03834753
What this trial is testing

A Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)

Who this might be right for
Age-related Macular DegenerationNeovascular Age-related Macular DegenerationWet Macular Degeneration
Outlook Therapeutics, Inc. 228
Large-scale testing (Phase 3)Active Not RecruitingNCT05407636
What this trial is testing

Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD

Who this might be right for
AMDnAMDWet Age-related Macular Degeneration+3 more
AbbVie 735
Post-approval studies (Phase 4)Study completedNCT05941715
What this trial is testing

Faricimab for High-frequent Aflibercept Treated Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration
Medical University of Graz 70
Post-approval studies (Phase 4)UnknownNCT02810808
What this trial is testing

Safety and Efficacy of Two Regimens of Ranibizumab 0.5 mg in Chinese Patients With Neovascular AMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 115
Next Page